Resources from the same session
1759MO - Associations between sarcopenia and gut microbiota in patients (pts) with metastatic renal cell carcinoma (mRCC) and breast cancer (BC)
Presenter: Zeynep Zengin
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
60MO - Gut microbiota and efficacy of immune-checkpoint inhibitors (ICIs) in patients (pts) with advanced solid tumor: SCRUM-Japan MONSTAR-SCREEN
Presenter: Kentaro Sawada
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
LBA68 - Clinical value of pre-treatment T-cell receptors (TCR) repertoire in non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy
Presenter: Afaf Abed
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
1760MO - Impact of immune checkpoint blockade therapy according to CD274 copy number alterations: A retrospective study in the ProfiLER cohort
Presenter: Khalil Hodroj
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
1761MO - Defining subset-wise myeloid responses to immune checkpoint blockade in melanoma
Presenter: Rosalin Cooper
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
61MO - Biomarker analysis of men with enzalutamide (enza)-resistant metastatic castration-resistant prostate cancer (mCRPC) treated with pembrolizumab (pembro) + enza in KEYNOTE-199
Presenter: Julie Graff
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
Discussion LBA68, 1760MO, 1761MO and 61MO
Presenter: Bertrand Routy
Session: Mini oral session - Translational research
Resources:
Slides
Webcast